Results 191 to 200 of about 13,600,961 (272)

Pregnancy outcomes following exposure to galcanezumab: Analysis of cases from the galcanezumab clinical trials and postmarketing database

Headache: The Journal of Head and Face Pain, Volume 66, Issue 10, Page 2240-2252, November/December 2026.
Abstract Objective This study was conducted to describe pregnancy outcomes reported following maternal or paternal exposure to galcanezumab in clinical trials and postmarketing surveillance. Background Galcanezumab is a calcitonin gene‐related peptide‐inhibiting monoclonal antibody indicated for the preventive treatment of migraine.
Irene Boz, Jan Lewis Brandes, Christopher Robinson, Maria Fernanda Scantamburlo Fernandes, Sarah Lipsius, LaRonda Morford, Enemona Emmanuel Adaji, Anaclara Prada Jardim, Holland C. Detke   +8 more
wiley   +1 more source

Cost-Utility Analysis of Calcitonin Gene-Related Peptide Monoclonal Antibodies for Patients with Episodic Migraine Headache in the USA. [PDF]

Pharmacoeconomics
Dong AW, Bounthavong M.
europepmc   +1 more source

Primary Small Cell Carcinoma of the Thyroid With Absent Calcitonin Expression: A Diagnostic Challenge

Pathology International, Volume 76, Issue 11, November 2026.
Primary small cell carcinoma of the thyroid is an exceptionally rare neuroendocrine malignancy with significant diagnostic challenges. We report a calcitonin‐negative thyroid neuroendocrine tumor with small cell morphology, absence of amyloid deposition, diffuse expression of neuroendocrine markers, no immunoreactivity for CGRP, and no RET/RAS ...
João Carlos Almeida, Patrícia Andrea‐Ferreira, Catarina Costa, Pedro Amoroso Canão, Elisabete Rodrigues, Manuel Sobrinho‐Simões, José Manuel Cameselle‐Teijeiro   +6 more
wiley   +1 more source

Astrocyte-Targeted Biomarkers for Calcitonin Gene-Related Peptide-Related Neurovascular Disorders: Insights from Calcium and Metabolic Profiling. [PDF]

ACS Omega
Phatruengdet T, Niraso B, Phiwchai I.
europepmc   +1 more source

Calcitonin Gene-Related Peptide Monoclonal Antibody Utilization and Treatment Gaps in People with Migraine in Japan: Results from the OVERCOME (Japan) 2nd Study. [PDF]

Drugs Real World Outcomes
Hanaoka Y, Takizawa T, Ishii R, Danno D, Hamakawa M, Ueda K, Tanizawa Y, Osaga S, Tharappel LJP, Hashimoto C.   +9 more
europepmc   +1 more source

Enteric glia, neuropeptides, and Parkinson's: impacts of calcitonin gene-related peptide on gut alpha synuclein. [PDF]

Am J Physiol Gastrointest Liver Physiol
Templeton HN, Lanser TB, Tobet SA, Schwerdtfeger LA.   +3 more
europepmc   +1 more source

ESTELA-Study: Long-Term Effectiveness and Safety of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in Real-World Clinical Practice. [PDF]

Brain Behav
Somovilla A, Fernández-Lázaro I, Pagán J, Saiz D, Díaz-De-Terán J, Portocarrero Sánchez L, Latorre G, Calle De Miguel C, González-García N, Cuadrado ML, Porta-Etessam J, Casas-Limón J, Garcia-Azorin D, Guerrero-Peral Á, González-Osorio Y, Gonzalez-Martinez A, Martín Ávila G, Terrero Carpio R, Rodríguez-Vico J, Jaimes A, Gómez García A, Trevino-Peinado C, Sanchez-Del-Rio M, Lozano Ros A, Sánchez-Soblechero A, Urtiaga Valle S, González-Salaices M, Riva E, Gago-Veiga A.   +28 more
europepmc   +1 more source

Amplifying and ameliorating light avoidance in mice with photoreceptor targeting and calcitonin gene-related peptide sensitization. [PDF]

Headache
Kaiser EA, Cavanah A, Aguirre GK, Jensen FE.   +3 more
europepmc   +1 more source

The role of amygdala calcitonin gene-related peptide receptors on the development of persistent bladder pain in mice. [PDF]

Pain
Lewter LA, Lewter LA, Paul BK, Salazar AM, Chatterjee UR, Pham HPT, Khan MZ, Schmitz AE, Nofal AM, Hussein MM, Mysorekar IU, Kolber BJ.   +11 more
europepmc   +1 more source

Amygdalar calcitonin gene-related peptide driven effects of cold sensitivity induced by peripheral neuropathy in mice. [PDF]

J Pain
Trail AD, Allen HN, Paul B, Nelson TS, Widner JA, Lewter L, Tack SH, Neilan RM, Kolber BJ.   +8 more
europepmc   +1 more source